A critical challenge to understanding, preventing and treating HIV and HIV-related diseases is the need for human clinical specimens and data from individuals with specific clinical and epidemiologic characteristics, and access to new, innovative laboratory tools needed to analyze biological specimens. The mission of the Clinical and Retrovirology Research Core (CRRC), a fusion of the Clinical Research and Retrovirology Cores, is to support access by local, regional and international investigators to clinical specimens, data and the assays they need to conduct clinical and translational HIV research projects. To accomplish this, the CRRC has developed specific resources to link participants recruited through the major UW-associated HIV clinics in Seattle (or samples and data from them) to individual HIV investigators. The CRRC will accomplish its mission in five ways: First, for investigators seeking eligible research subjects to enroll in specific studies, the CRRC will continue the highly successful Research Referral Service. Second, for translational investigators seeking human specimens, the CRRC will use two approaches with complementary strengths: 1) a more limited version of the existing HIV Specimen Repository with prospective follow-up and routine specimen and data collection, and 2) an enhanced version of the existing Special Specimen Collection Service with specific project-directed collection of specimens and data. Third, to address the need for control specimens from HIV-negative persons, the CRRC will establish a new registry of HIV negative patients interested in participating in HIV research studies. Fourth, to support laboratory analyses for specific HIV studies, the CRRC will provide basic testing and develop specialized laboratory assays required for specific HIV studies. Finally, to accelerate the pace of planned studies and stimulate new directions of research, the CRRC will create and strengthen linkages with other UW CFAR cores and other CFARs (CNICS). Specifically, the CRRC will coordinate regular meetings with the immunology, clinical epidemiology and computational biology cores to scrutinize and integrate requests for services made to any of the cores and maximize efficient and novel uses of samples and laboratory testing capacity.

Public Health Relevance

The new CRRC will be essential to clinical investigators who must recruit subjects into research studies, to basic scientists needing access to the human specimens necessary to the conduct of bench experiments and to translational scientists who require both clinical data (phenotypes) and biological specimens to study the pathogenesis of HIV disease and determine the biological correlates of HIV transmission and disease progression

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-27
Application #
8683036
Study Section
Special Emphasis Panel (ZAI1-UKS-A)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
27
Fiscal Year
2014
Total Cost
$435,791
Indirect Cost
$108,380
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Coban, Hamza; Robertson, Kevin; Smurzynski, Marlene et al. (2017) Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen. AIDS 31:1565-1571
Goyette, Marielle S; Wilson, Kate S; Deya, Ruth et al. (2017) Brief Report: Association Between Menopause and Unprotected Sex in High-Risk HIV-Positive Women in Mombasa, Kenya. J Acquir Immune Defic Syndr 74:488-492
LaCourse, Sylvia M; Deya, Ruth W; Graham, Susan M et al. (2017) Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 76:74-81
Dross, Sandra E; Munson, Paul V; Kim, Se Eun et al. (2017) Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol 198:757-766
Drozd, Daniel R; Saag, Michael S; Westfall, Andrew O et al. (2017) Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice. Medicine (Baltimore) 96:e6275
Dombrowski, Julia C; Bove, Joanna; Roscoe, James C et al. (2017) ""Out of Care"" HIV Case Investigations: A Collaborative Analysis Across 6 States in the Northwest US. J Acquir Immune Defic Syndr 74 Suppl 2:S81-S87
Mugwanya, Kenneth K; John-Stewart, Grace; Baeten, Jared (2017) Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women. Expert Opin Drug Saf 16:867-871
Puttkammer, Nancy; Domerçant, Jean Wysler; Adler, Michelle et al. (2017) ART attrition and risk factors among Option B+ patients in Haiti: A retrospective cohort study. PLoS One 12:e0173123
Koelle, David M; Norberg, Peter; Fitzgibbon, Matthew P et al. (2017) Worldwide circulation of HSV-2?×?HSV-1 recombinant strains. Sci Rep 7:44084
Barbee, Lindley A; Khosropour, Christine M; Dombrowksi, Julia C et al. (2017) New Human Immunodeficiency Virus Diagnosis Independently Associated With Rectal Gonorrhea and Chlamydia in Men Who Have Sex With Men. Sex Transm Dis 44:385-389

Showing the most recent 10 out of 1172 publications